Skip to main content
    B

    Bio Green Med Solution, Inc. (BGMS)

    Official site

    INDUSTRIALS • BUILDING PRODUCTS & EQUIPMENT • NASDAQ

    $0.65
    +0.01 (+1.55%)

    Market Cap: $4.24M

    Last updated: Nov 17, 2026 at 10:59 AM ET

    Bio Green Med Solution, Inc. (BGMS) Financials: Revenue, Profit and Cash Flow

    Updated Nov 12, 2026. Financial statements from company filings, amounts in US dollars.

    Bio Green Med Solution reported revenue of $747.00K for the fiscal year ended Dec 31, 2025, up 1637.2% from the year before. That year, net income was -$3.00M with a net margin of -401.3%, operating cash flow was -$4.77M and free cash flow was -$4.77M. The quarter ended Sep 30, 2026 had revenue of $454.00K and net income of -$449.00K.

    Revenue and Margins

    Over the 9 years to Dec 2025, revenue fell from $843.00K, a compound annual decline of 1.3%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$747.00K+1637.2%18.5%-1128.1%-401.3%
    Dec 2024$43.00K-89.8%100.0%-27916.3%-26074.4%
    Dec 2023$420.00KN/A100.0%-6060.2%-5370.2%
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0N/AN/AN/AN/A
    Dec 2019$0-100.0%N/AN/AN/A
    Dec 2018$150.00KN/A100.0%-6365.3%-4858.7%
    Dec 2017$0-100.0%N/AN/AN/A
    Dec 2016$843.00KN/A100.0%-1678.5%-1398.7%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss narrowed from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$747.00K$43.00K$420.00K$0$0$0$0$150.00K$0$843.00K
    Cost of revenue$609.00K$0$0$0$0$0$0$0$0$0
    Gross profit$138.00K$43.00K$420.00K$0$0$0$0$150.00K$0$843.00K
    Research and development$848.00K$6.66M$19.16M$20.27M$14.93M$4.76M$4.66M$4.33M$4.24M$9.48M
    Operating income-$8.43M-$12.00M-$25.45M-$27.66M-$22.39M-$10.64M-$9.68M-$9.55M-$9.49M-$14.15M
    Net income-$3.00M-$11.21M-$22.55M-$21.20M-$18.46M-$8.45M-$7.83M-$7.29M-$7.47M-$11.79M
    EBITDA-$8.00M-$12.00MN/A-$26.09M-$22.16M-$9.70M-$9.33M-$8.93M-$8.55M-$13.68M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$454.00K$336.00K$778.00K$666.00K$81.00K$0$0$0$10.00K$0$0$388.00K
    Gross profit$115.00K$79.00K$143.00K$121.00K$17.00K$0$0-$1.00K$10.00K$0$0$388.00K
    Operating income-$520.00K-$418.00K-$246.00K-$1.08M-$987.00K-$1.25M-$4.21M-$1.83M-$2.18M-$3.64M-$4.36M-$7.64M
    Net income-$449.00K-$405.00K-$197.00K-$611.00K-$988.00K-$1.32M-$81.00K-$3.05M-$1.96M-$3.26M-$2.95M-$7.46M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents of $3.50M were 42.7% of total assets of $8.19M, against total liabilities of $1.34M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$8.19M$4.09M$8.80M$28.05M$43.14M$36.80M$15.31M$19.82M$26.00M$19.66M
    Current assets$6.26M$3.67M$7.44M$24.41M$40.94M$35.47M$14.02M$19.79M$25.97M$19.62M
    Cash and equivalents$3.50M$3.14M$3.38M$18.34M$36.56M$33.41M$11.88M$17.50M$23.91M$16.52M
    Total liabilities$1.34M$6.27M$8.20M$7.62M$5.44M$3.54M$3.61M$4.55M$4.24M$5.39M
    Shareholder equity$6.84M-$2.17M$607.00K$15.94M$37.69M$33.26M$11.70M$15.27M$21.77M$14.27M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$7.48M$7.85M$7.56M$8.19M$8.16M$4.40M$3.73M$4.09M$5.38M$8.19M$6.17M$8.80M
    Total liabilities$817.00K$694.00K$804.00K$1.34M$1.06M$770.00K$672.00K$6.27M$6.35M$7.19M$8.37M$8.20M
    Cash and equivalents$3.45M$3.79M$3.34M$3.50M$3.84M$4.28M$3.45M$3.14M$2.98M$6.00M$2.80M$3.38M
    Shareholder equity$6.66M$7.16M$6.76M$6.84M$7.10M$3.63M$3.06M-$2.17M-$970.00K$999.00K-$2.21M$607.00K
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$4.77M-$7.99M-$16.11M-$20.83M-$18.54M-$7.93M-$9.45M-$6.70M-$7.48M-$10.08M
    Capital expenditures$0$0$6.00K$7.00K$27.00K$96.00K$10.00K$39.00K$13.00K$3.00K
    Free cash flow-$4.77M-$7.99M-$16.12M-$20.83M-$18.57M-$8.03M-$9.46M-$6.74M-$7.49M-$10.08M
    Dividends paid$61.00K$0$201.00K$201.00K$201.00K$201.00K$201.00K$201.00K$201.00K$200.00K
    Investing cash flow$0$0-$6.00K-$7.00K-$27.00K-$96.00K$28.00K-$39.00K-$13.00K$9.00K
    Financing cash flow$5.26M$7.82M$848.00K$3.00M$21.74M$29.50M$3.85M$429.00K$14.75M$6.59M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$287.00K-$352.00K-$278.00K-$33.00K-$434.00K-$1.06M-$3.25M-$1.36M-$3.07M$3.29M-$483.00K-$3.91M
    Capital expendituresN/AN/A$1.00K$0$0$0$0$0$0$6.00K$0$0
    Free cash flowN/AN/A-$279.00K-$33.00K-$434.00K-$1.06M-$3.25M-$1.36M-$3.07M$3.29M-$483.00K-$3.91M
    Last 12 quarters

    Frequently Asked Questions About BGMS

    What is Bio Green Med Solution's annual revenue?

    Bio Green Med Solution reported revenue of $747.00K for the fiscal year ended Dec 31, 2025.

    How fast is Bio Green Med Solution's revenue growing?

    Revenue was up 1637.2% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is Bio Green Med Solution profitable?

    No. Bio Green Med Solution reported net income of -$3.00M for the fiscal year ended Dec 31, 2025, with a net margin of -401.3%.

    How much free cash flow does BGMS generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$4.77M minus capital expenditures of $0 produced free cash flow of -$4.77M.

    How much debt does Bio Green Med Solution have?

    The balance sheet dated Dec 31, 2025 reported cash and equivalents of $3.50M.